Year Established :
2013
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
50-100
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
The company's R&D headquarters is located in Beijing Fengtai Science and Technology Park, with complete molecular biology, synthetic biology and fermentation laboratories. The R&D team is composed of well-known domestic universities and personnel studying in the United States and Germany, with a bachelor degree of 100%. The company's research and development of GSH, NMN and other production technologies are internationally leading, all of which are self-developed enzymatic technology and have obtained a number of national patents.
Patents and Copyrights :
In the past six years, our R&D was dedicating to the study of our pruducts and won Six China Invention Patents.
Meanwhile, we have also applied for various product certificates, such as KOSHER, HALAL, ISO9001, FDA, etc.
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Seven years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
